Mini Review
Published: 25 March, 2026 | Volume 9 - Issue 1 | Pages: 018-021
Antimicrobial resistance (AMR) is a serious global health crisis. It is getting worse every year. Low- and middle-income countries (LMICs) are the most affected. This is mainly because infectious diseases are very common there. Poor water, sanitation, and hygiene (WASH) systems make things worse. On top of that, vaccination rates in these countries remain very low. All these factors together make AMR a much bigger threat in LMICs than anywhere else.
The recent data showed that bacterial AMR was linked to about 4.95 million deaths worldwide, and 1.27 million of the deaths were directly attributable in 2019. Using information from the Global Burden of Diseases, Injuries and Risk Factors Study 2021. The GBD Antimicrobial Resistance Collaborators employed statistical modelling to evaluate AMR trends from 1990 to 2021 and to forecast the burden through 2050 across 204 nations and territories.
The results are concerning. AMR-related deaths have increased significantly. Older adults aged 70 and above are the most affected group. However, there is some good news too. Deaths among children under five have dropped by nearly 50%. This is a big achievement. Better infection prevention has played a major role in this. Vaccination programs have also made a real difference. Improved water and sanitation (WASH) initiatives have helped as well. These combined efforts have clearly saved many young lives.
Key pathogens contributing to AMR mortality include Klebsiella pneumoniae, Escherichia coli, Streptococcus pneumoniae and meticillin-resistant Staphylococcus aureus (MRSA). In the absence of improved interventions, deaths attributable to AMR are anticipated to rise to 1.91 million annually by 2050. It is important to strengthen infection prevention, surveillance, vaccination, and WASH with integrated One Health approaches to ease the future impact of AMR.
Read Full Article HTML DOI: 10.29328/journal.ijcmbt.1001035 Cite this Article Read Full Article PDF
Antimicrobial resistance; Global health burden; Infectious disease epidemiology; Antibiotic resistance; Global burden of disease study; Low- and middle-income countries; Antimicrobial stewardship; Public health policy
If you are already a member of our network and need to keep track of any developments regarding a question you have already submitted, click "take me to my Query."